Private Equity
Fusion Pharmaceuticals Inc, a newly-formed Canadian biopharmaceutical company, has raised about $33 million (US$25 million) in a Series A financing. The round was led by Johnson & Johnson Innovation-JJDC Inc and joined by HealthCap, TPG Biotech, Genesys Capital and FACIT. Hamilton, Ontario's Fusion is a spin-out from the Centre for Probe Development and Commercialization, located at McMaster University. Led by that organization's founder, Dr. John Valliant, Fusion is focused on developing targeted radiotherapeutics for treating cancer. It will use the funds raised to bring its lead program, FPX-01, into human clinical trials.
5 min read · 23 February 2017
K2 Global has raised $183 million for its venture fund. Based in Silicon Valley and Singapore, K2 Global backs tech companies in the internet and software sectors. According to the firm, it has invested $58 million in ten companies so far, which include Magic Leap, Spotify and Uber.
4 min read · 23 February 2017
Xsolla Inc. launched a $30 million Xsolla Capital royalty investment fund to provide backing for independent video game developers, according to a press release.
1 min read · 23 February 2017
4 min read · 22 February 2017
2 min read · 22 February 2017
Berlin-based Project A, an early-stage investment firm, has closed its second fund at 140 million euros. The investors of the fund included Otto Group, Axel Springer SE, the European Investment Fund. ProSiebenSat.1, Jahr, Haniel, Ravensburger and Oetker. Also, Project A is about to close another fund at 40 million euros focused on follow-on investments in its portfolio companies.
2 min read · 22 February 2017
TrueBridge Capital Partners has closed its first direct fund at $125 million, beating its $100 million target. TrueBridge Direct Fund LP will focus on mid- to late-stage tech companies mostly in the United States, with a particular emphasis on Silicon Valley.
3 min read · 22 February 2017
5 min read · 22 February 2017
1 min read · 22 February 2017
1 min read · 22 February 2017
